000 | 02223 a2200565 4500 | ||
---|---|---|---|
005 | 20250516070122.0 | ||
264 | 0 | _c20120326 | |
008 | 201203s 0 0 eng d | ||
022 | _a1179-187X | ||
024 | 7 |
_a10.2165/11593800-000000000-00000 _2doi |
|
040 |
_aNLM _beng _cNLM |
||
100 | 1 | _aCai, Jingjing | |
245 | 0 | 0 |
_aComparing antihypertensive effect and plasma ciclosporin concentration between amlodipine and valsartan regimens in hypertensive renal transplant patients receiving ciclosporin therapy. _h[electronic resource] |
260 |
_bAmerican journal of cardiovascular drugs : drugs, devices, and other interventions _cDec 2011 |
||
300 |
_a401-9 p. _bdigital |
||
500 | _aPublication Type: Comparative Study; Journal Article; Randomized Controlled Trial; Research Support, Non-U.S. Gov't | ||
650 | 0 | 4 | _aATP Binding Cassette Transporter, Subfamily B |
650 | 0 | 4 |
_aATP Binding Cassette Transporter, Subfamily B, Member 1 _xgenetics |
650 | 0 | 4 | _aAdult |
650 | 0 | 4 |
_aAmlodipine _xpharmacology |
650 | 0 | 4 |
_aAntihypertensive Agents _xpharmacology |
650 | 0 | 4 |
_aBlood Pressure _xdrug effects |
650 | 0 | 4 |
_aCyclosporine _xpharmacokinetics |
650 | 0 | 4 |
_aCytochrome P-450 CYP3A _xgenetics |
650 | 0 | 4 | _aDouble-Blind Method |
650 | 0 | 4 | _aDrug Interactions |
650 | 0 | 4 | _aFemale |
650 | 0 | 4 | _aGenotype |
650 | 0 | 4 | _aHumans |
650 | 0 | 4 |
_aHypertension _xdrug therapy |
650 | 0 | 4 |
_aImmunosuppressive Agents _xpharmacokinetics |
650 | 0 | 4 |
_aKidney Transplantation _xmethods |
650 | 0 | 4 | _aMale |
650 | 0 | 4 | _aPolymerase Chain Reaction |
650 | 0 | 4 | _aPolymorphism, Restriction Fragment Length |
650 | 0 | 4 | _aProspective Studies |
650 | 0 | 4 |
_aTetrazoles _xpharmacology |
650 | 0 | 4 |
_aValine _xanalogs & derivatives |
650 | 0 | 4 | _aValsartan |
700 | 1 | _aHuang, Zhijun | |
700 | 1 | _aYang, Guoping | |
700 | 1 | _aCheng, Ke | |
700 | 1 | _aYe, Qifa | |
700 | 1 | _aMing, Yingzi | |
700 | 1 | _aZuo, Xiaocong | |
700 | 1 | _aZhou, Peipei | |
700 | 1 | _aYuan, Hong | |
773 | 0 |
_tAmerican journal of cardiovascular drugs : drugs, devices, and other interventions _gvol. 11 _gno. 6 _gp. 401-9 |
|
856 | 4 | 0 |
_uhttps://doi.org/10.2165/11593800-000000000-00000 _zAvailable from publisher's website |
999 |
_c21372919 _d21372919 |